Abstract
This study from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress during the second year of the patients in a concurrent comparison of four domiciliary chemotherapeutic regimens (isoniazid plus PAS and three regimens of isoniazid alone) who had bacteriologically active or bacteriologically relapsed pulmonary tuberculosis, with isoniazid-resistant organisms, at the end of the first year of treatment.
Of the 57 patients who continued on the same chemotherapy during the second year, nine had attained bacteriological quiescence by the end of that year, 15 still had bacteriologically active disease and 33 had during the year had a serious radiographic deterioration necessitating a change of treatment. An association was observed between the response to treatment in the second year and both the extent of cavitation and the degree of culture-positivity at the end of the first year, but no association was found between the response to treatment in the second year and the level of isoniazid-resistance, the catalase activity, the susceptibility to hydrogen peroxide or the virulence in the guinea-pig of cultures isolated in the last months of the first year.
It is concluded that persisting bacteriological positivity at the end of one year's treatment with isoniazid, either alone or in combination with PAS, is likely to lead to serious radiographic deterioration, irrespective of the level of isoniazid-resistance or of the catalase activity of the cultures of tubercle bacilli, and that, consequently, treatment of patients with bacteriologically active pulmonary tuberculosis must aim at rendering the sputum culture-negative in all instances.
Full text
PDF

















Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARNETT M., BUSBY S. R., MITCHISON D. A. Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice. Br J Exp Pathol. 1953 Oct;34(5):568–581. [PMC free article] [PubMed] [Google Scholar]
- COHN M. L., KOVITZ C., ODA U., MIDDLEBROOK G. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc. 1954 Oct;70(4):641–664. doi: 10.1164/art.1954.70.4.641. [DOI] [PubMed] [Google Scholar]
- DEUSCHLE K., ORMOND L., ELMENDORF D., Jr, MUSCHENHEIM C., McDERMOTT W. The course of pulmonary tuberculosis during long-term single-drug (isoniazid) therapy. Am Rev Tuberc. 1954 Aug;70(2):228–265. doi: 10.1164/art.1954.70.2.228. [DOI] [PubMed] [Google Scholar]
- DEVADATTA S., GANGADHARAM P. R., ANDREWS R. H., FOX W., RAMAKRISHNAN C. V., SELKON J. B., VELU S. Peripheral neuritis due to isoniazid. Bull World Health Organ. 1960;23:587–598. [PMC free article] [PubMed] [Google Scholar]
- KREIS B., LE JOUBIOUX E., PARIENTE D. Hétérogenéité des taux catalasiques dans les populations de bacilles tuberculeux isoniazido-resistantes. Ann Inst Pasteur (Paris) 1956 Dec;91(6):932–935. [PubMed] [Google Scholar]
- MIDDLEBROOK G., COHN M. L. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science. 1953 Sep 11;118(3063):297–299. doi: 10.1126/science.118.3063.297. [DOI] [PubMed] [Google Scholar]
- MIDDLEBROOK G., DRESSLER S. H. Clinical evaluation of isoniazid. Am Rev Tuberc. 1954 Dec;70(6):1102–1103. doi: 10.1164/art.1954.70.6.1102. [DOI] [PubMed] [Google Scholar]
- MITCHISON D. A., BHATIA A. L., RADHAKRISHNA S., SELKON J. B., SUBBAIAH T. V., WALLACE J. G. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test. Bull World Health Organ. 1961;25:285–312. [PMC free article] [PubMed] [Google Scholar]
- MITCHISON D. A. Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs. Br Med J. 1954 Jan 16;1(4854):128–130. doi: 10.1136/bmj.1.4854.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MORSE W. C., WEISER O. L., KUHNS D. M., FUSILLO M., DAIL M. C., EVANS J. R. Study of the virulence of isoniazid-resistant tubercle bacilli in guinea pigs and mice; a preliminary report. Am Rev Tuberc. 1954 Mar;69(3):464–468. doi: 10.1164/art.1954.69.3.464. [DOI] [PubMed] [Google Scholar]
- OESTREICHER R., DRESSLER S. H., RUSSELL W. F., Jr, GROW J. B., MIDDLEBROOK G. Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculous patients. Am Rev Tuberc. 1955 Mar;71(3 Pt 1):390–405. doi: 10.1164/artpd.1955.71.3-1.390. [DOI] [PubMed] [Google Scholar]
- PEIZER L. R., WIDELOCK D., KLEIN S. Virulence in guinea pigs of isoniazidresistant cultures isolated from clinical specimens; a preliminary report. Am Rev Tuberc. 1953 Aug;68(2):290–291. doi: 10.1164/art.1953.68.2.290. [DOI] [PubMed] [Google Scholar]
- VELU S., ANDREWS R. H., ANGEL J. H., DEVADATTA S., FOX W., GANGADHARAM P. R., NARAYANA A. S., RAMAKRISHNAN C. V., SELKON J. B., SOMASUNDARAM P. R. Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate. Bull World Health Organ. 1961;25:409–429. [PMC free article] [PubMed] [Google Scholar]